Overview

Open-Label Depakote ER in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence

Status:
Withdrawn
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if Divalproex Sodium can be used to Treat and Prevent Depression in Patients with Bipolar Disorder who have Comorbid Alcohol Dependence/Abuse.
Phase:
Phase 2
Details
Lead Sponsor:
The University of Texas Medical Branch, Galveston
Treatments:
Ethanol
Valproic Acid